Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Organogenesis history
Organogenesis company history timeline
1998: FDA approves Apligraf® for the treatment of venous leg ulcers
2000: FDA approves Apligraf® for the treatment of diabetic foot ulcers
On the strength of sales of Apligraf, a skin replacement for venous leg and diabetic foot ulcers, the private company's sales to hospitals and third-party vendors have increased by more than 30 percent every year since 2003, said Gillheeney, who declined to release exact financial figures.
An IPO would also be a liquid event for investors who took the business private as part of a plan to lift the company from bankruptcy in 2003.
2004: Launch of full USA sales and marketing organization
The United States market for tissue engineered skin replacements and wound repair modulators was $195 million in 2004 and is expected to reach $481 million within eight years, according to a market study by Medtech Insight, a medical industry analysis firm in Newport Beach, Calif.
2006: European office established in Switzerland
The company opened a research-and-development facility in October in Lyon, France, and plans now include the launch of at least two new products in 2007.
It also plans in 2007 to offer an anti-microbial wound dressing with dermal scaffolds onto which the body's cells migrate to promote healing.
In fact, the company plans to build its sales force to 100 people by the end of 2007. "It really has been an amazing turnaround," Gillheeney said.
Novartis at that time returned the marketing rights of Apligraf to Organogenesis, which included giving the Swiss drug giant royalties of product sales until 2010.
In 2014, our product portfolio expanded to include Dermagraft®, an FDA-approved therapy for the treatment of diabetic foot ulcers.
The launch of our PuraPly® product line in 2015 gave clinicians new options for wound management across a variety of acute and chronic wound types.
In 2017, Organogenesis acquired NuTech Medical, which further expanded our product portfolio and introduced additional solutions for the advanced wound care market and enabled us to enter the surgical and sports medicine markets in a meaningful way.
© 2017 Simian and Bissell.
2018: Organogenesis becomes a public company through merger with Avista Healthcare
2020: Acquires CPN Biosciences
Rate how well Organogenesis lives up to its initial vision.
Organogenesis jobs
Do you work at Organogenesis?
Does Organogenesis communicate its history to new hires?
Organogenesis competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cardium Therapeutics | 2003 | $1.6M | 30 | - |
| Liveyon | 2016 | $1.9M | 75 | - |
| SpineSmith | 2006 | $13.0M | 300 | - |
| Stratatech Corporation | 2000 | $7.1M | 20 | - |
| Humabiologics | 2018 | $270,000 | 11 | - |
| Alafair Biosciences | 2011 | $2.1M | 15 | - |
| LifeSprout | 2015 | $1.1M | 15 | - |
| MiMedx | 2008 | $348.9M | 690 | 34 |
| Semrock Filters | 2000 | $13.0M | 125 | - |
| IDEXX | 1983 | $3.9B | 9,300 | 192 |
Organogenesis history FAQs
Zippia gives an in-depth look into the details of Organogenesis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Organogenesis. The employee data is based on information from people who have self-reported their past or current employments at Organogenesis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Organogenesis. The data presented on this page does not represent the view of Organogenesis and its employees or that of Zippia.
Organogenesis may also be known as or be related to Organogenesis, Organogenesis Inc and Organogenesis Inc.